Management outlined ongoing R&D investment and milestone-based payments on licensing agreements as financial commitments.
Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...
Atos Group has Delivered on its Commitments to Restore its Foundations Growth Chapter Ready to be Opened FY 2025 financial and extra financial targets met or exceeded: Revenue at €8,001 million, ...
The Caribbean Development Bank (CDB) is keen on improving trade financing to boost the movement of goods between Caribbean nations, and is encouraging Caribbean nationals to take advantage of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results